Callicarpa nudiflora -Derived Extracellular Vesicle-Based Hydrogel Loaded with Apremilast for Enhanced Therapy of Psoriasis
ACS Applied Bio Materials · 02.11.2026 · 9 (21) · 10479-10496
DOI: 10.1021/acsabm.6c01702 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 14.10.2026. Verfasst von Yingmiao Ou und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang330031, China. Hauptthemen laut MEDLINE: Psoriasis, Hydrogels, Thalidomide, Extracellular Vesicles. Die Arbeit nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Apremilast (APST) is an effective medication for psoriasis, but its clinical application is limited by its exclusive availability as an oral tablet formulation and the associated systemic adverse effects. Hydrogel-based transdermal delivery offers a promising alternative for localized APST administration. To address this, Callicarpa nudiflora-derived extracellular vesicle-based hydrogel loaded with APST (APST-EV-Gel) was developed. APST was first loaded into Callicarpa nudiflora-derived extracellular vesicles (APST-EVs) with a drug loading of 17.14% ± 0.13% and an encapsulation efficiency of 41.49% ± 0.48%. The resulting APST-EVs were then embedded in a carbomer hydrogel to form APST-EV-Gel. Pharmacodynamic evaluation demonstrated that APST-EV-Gel significantly ameliorated skin lesions and reduced splenic inflammation in mice. The treatment also decreased infiltration of T-lymphocytes and neutrophils, downregulated the proliferation marker Ki67, and markedly lowered levels of the inflammatory cytokines TNF-α, IL-17, and IL-23. Furthermore, APST-EV-Gel promoted apoptosis in hyperproliferative keratinocytes, thereby contributing to disease alleviation. In conclusion, the combination of APST and EVs exerts superior therapeutic efficacy against psoriasis compared to monotherapy with either agent alone. APST-EV-Gel represents a promising topical therapeutic strategy for psoriasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang330031, China.
- Key Laboratory of New Drug Transformation and Evaluation of Jiangxi Province , Nanchang330031, China.
- Jiangxi Prozin Pharmaceutical Co., Ltd , Jian343100, China.
- Jiangxi Shunfutang Chinese Herbal Pieces Co., Ltd. , Jian331400, China.
- Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang330006, China.
ORCID-Profile: Feng Guo
Förderung
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Ou, Y., Pei, B., Wang, C., Chen, L., Zhu, J., Xu, P., Zhong, H., Zhang, H., & Guo, F. (2026). Callicarpa nudiflora -Derived Extracellular Vesicle-Based Hydrogel Loaded with Apremilast for Enhanced Therapy of Psoriasis. ACS Applied Bio Materials, 9(21), 10479-10496. https://doi.org/10.1021/acsabm.6c01702
Vancouver
Ou Y, Pei B, Wang C, Chen L, Zhu J, Xu P, et al. Callicarpa nudiflora -Derived Extracellular Vesicle-Based Hydrogel Loaded with Apremilast for Enhanced Therapy of Psoriasis. ACS Applied Bio Materials. 2026;9(21):10479-10496. doi:10.1021/acsabm.6c01702
BibTeX
@article{Ou2026,
author = {Ou, Yingmiao and Pei, Baoliang and Wang, Chong and Chen, Liang and Zhu, Jizhou and Xu, Peng and Zhong, Haijun and Zhang, Hongbo and Guo, Feng},
title = {Callicarpa nudiflora -Derived Extracellular Vesicle-Based Hydrogel Loaded with Apremilast for Enhanced Therapy of Psoriasis},
journal = {ACS Applied Bio Materials},
year = {2026},
volume = {9},
number = {21},
pages = {10479--10496},
doi = {10.1021/acsabm.6c01702}
}
EUVIMED